Cancer Research UK and Dewpoint Therapeutics Partner to Advance MYC-Targeting Cancer Drug into Phase 1/2a Trial

DPTX8743 is a potential first-in-class small molecule modulator of MYC condensates, targeting one of cancer’s most important and historically undrugg...

November 18, 2026 | Wednesday | News
Centrix Pharma Solutions Appoints Dr Nathalie Huther as SVP of Business Development and Commercial

Centrix Pharma Solutions, a UK-based Contract Development Manufacturing Organisation (CDMO), has appointed Dr Nathalie Huther as Senior Vice President of B...

November 11, 2026 | Wednesday | News
Essential Pharma and Nordmark Partner to Launch UK-Approved Norzyme for Pancreatic Exocrine Insufficiency

Partnership brings together decades of pancreatin experience at Nordmark and Essential Pharma Norzyme® (pancreas powder) 25,000 gastro-resistant capsu...

November 10, 2026 | Tuesday | News
MediPharm Labs Secures Positive EU Regulatory Opinion for Cannabinoid Inhaler Ahead of 2027 UK and European Launch

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmace...

November 09, 2026 | Monday | News
Pharming Secures UK MHRA Approval for Joenja in Children Aged 4 to 11 with Rare Immune Disorder APDS

Approval extends existing U.K. indication for Joenja to eligible children aged 4 to 11 who weigh at least 27 kg Joenja is expected to become available t...

November 09, 2026 | Monday | News
Ultragenyx Secures UK MHRA Review of UX111 Gene Therapy for Sanfilippo Syndrome Type A

Ultragenyx (NASDAQ:RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ultra-rare genetic d...

November 09, 2026 | Monday | News
Link Biologics Completes Preclinical Studies for LB001 Dry Eye Disease Treatment Ahead of 2027 Clinical Trials

Completion of key IND-enabling activities represents a major development milestone for LB001 IND submission remains on track for Q1 2027, followed by in...

November 06, 2026 | Friday | News
AbbVie and Nxera Pharma Sign Potential US$1.47 Billion Licensing Deal for Inflammatory Bowel Disease Drug

Nxera to receive US$100 million upfront and be eligible for up to US$1.37 billion in development and commercial milestone payments, plus tiered royalties...

November 05, 2026 | Thursday | News
BioAgilytix Expands Global Bioanalytical Capabilities Through New 360biolabs Sydney Laboratory

BioAgilytix, a  global bioanalytical Contract Research Organization (CRO), announces the expansion of its  Australian laboratories through the op...

October 27, 2026 | Tuesday | News
Merck to Acquire Silence Therapeutics for $1.3 Billion to Expand Rare Disease Pipeline

Purchase price of $20 per ADS in cash represents an enterprise value of $1.1 billion and an equity value of approximately $1.3 billion Silence Therapeut...

October 22, 2026 | Thursday | News
Alvotech Secures FDA Approval for New SIMLANDI Manufacturing Process, Doubling Batch Output

Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worl...

October 21, 2026 | Wednesday | News
Samsung Biologics Secures Court Injunction to Maintain Production During Industrial Action

Samsung Biologics (KRX: 207940.KS) confirmed that the Seoul High Court has ruled in the company's favor, granting an injunction prohibiting industrial acti...

October 20, 2026 | Tuesday | News
Mursla Bio Study Validates Tissue-Specific Liquid Biopsy Platform

Study published in Journal of Extracellular Vesicles validates platform for new class of liquid biopsy: multiomic disease biology of living cells from ...

October 14, 2026 | Wednesday | News
Andelyn Biosciences and PQP Group Partner on EU and UK Gene Therapy Supply

Andelyn Biosciences (“Andelyn”), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization (...

October 09, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close